Not Every Treatment Is a Spa Day: What to Know About JOURNAVX

by | All, Laser & Devices

Full-face Hybrid resurfacing does not feel nice. I’m not going to pretend otherwise. It’s one of the spiciest treatments we offer, and patients keep booking it because the results are worth it. But if I told you it felt “a little warm,” I’d be lying to you, and I don’t do that.

Most of what we do isn’t at that level. PixelPeel is spicy for a few minutes and most people skip numbing entirely. Our deeper resurfacing is different, and every one of those appointments already includes topical numbing and cooling. Now there’s one more thing I can offer some of you: a non-opioid prescription you take at home before you come in. It’s called JOURNAVX.

I want to walk you through it honestly, including where it falls short, so you can decide if it’s worth it for you.

So what is it?

JOURNAVX (suzetrigine) is a prescription pain medication from Vertex Pharmaceuticals, and it is not an opioid. The FDA approved it in January 2025 for adults with moderate-to-severe short-term pain. In January 2026, the label was updated to name postoperative pain specifically.

It’s the first new class of pain medication approved in over 20 years. That’s what made me look. The way it works is what made me want to offer it.

How it works (bear with me, this part matters)

Most strong pain meds work on your brain. That’s why they can leave you foggy or nauseous, and it’s why opioids come with a risk of dependence.

JOURNAVX works out at the nerves. It blocks a sodium channel called NaV1.8 on the nerves that sense pain, which turns the signal down before it ever reaches your spinal cord and brain.

What that means for you:

  • It isn’t an opioid, and it isn’t a controlled substance.
  • Because it doesn’t act on the brain the way opioids do, it doesn’t sedate you the way they do.
  • Most people in the clinical trials had mild side effects or none at all.

What the research actually shows

It was approved based on two big trials in people recovering from surgery (one tummy tuck, one bunion procedure). It clearly beat placebo. It did not beat the standard opioid combination it was compared against, and I’d rather you hear that from me than stumble on it later. The most common side effects were itching, muscle spasms, rash and a change in a lab marker of muscle activity. Each showed up in roughly 1 to 2 out of every 100 people.

The study that’s closest to what we do came out in March 2026. Ninety-nine adults having aesthetic and reconstructive plastic surgery (breast procedures, liposuction, tummy tucks) took JOURNAVX before and after surgery, along with acetaminophen and ibuprofen.

  • 90.9% needed no rescue opioids through the end of treatment, which lasted up to 14 days.
  • 90.7% rated their pain control good, very good or excellent.
  • No serious drug-related side effects were reported.

Two caveats you should know about. There was no comparison group, and the manufacturer paid for the study. I find the results encouraging, but they aren’t the final word.

How we use it at Flora

If it’s a good fit for you, you’ll take it at home before your appointment, timed so it’s working by the time we start. I’ll give you exact instructions at your consult.

And I’d rather under-promise here, so let me be clear about what to expect:

  • It takes the edge off. It’s not a numbing agent, and extra spicy will still feel spicy.
  • We still do all of our usual comfort measures. Topical numbing and cooling happen either way.
  • It’s meant for treatment day. One dose before your appointment isn’t designed to cover the 24 to 72 hours afterward, when tenderness can peak. If your recovery is rougher than you expected, please tell me instead of toughing it out quietly. We have options.

The off-label part

JOURNAVX is FDA-approved for moderate-to-severe acute pain, and it was studied after surgery. Using it before a cosmetic treatment is considered “off-label.” That’s legal and based on clinical judgment, but it isn’t the specific use the FDA reviewed.

Off-label prescribing happens all the time in medicine. Still, there’s no published research yet on taking a dose before an aesthetic treatment. My recommendation is based on how the drug works and its safety record, and I want you to know that before you decide.

Who shouldn’t take it

Please tell me before your appointment if any of these apply to you:

  • You’re pregnant, might be pregnant, or you’re breastfeeding. We won’t use it.
  • You have significant liver or kidney disease.
  • You take medications or supplements that interact with it. That includes some antifungals, certain antibiotics, Paxlovid, some heart and seizure medications, and St. John’s wort. Some of these just mean a dose change. Others rule JOURNAVX out.
  • You love grapefruit. Skip it completely while you’re taking JOURNAVX. Seriously.

At your consult I’ll go through your full medication list with you, including anything over the counter. And yes, your supplements too.

Please don’t skip this: birth control

JOURNAVX can make some hormonal birth control less effective. If yours contains a progestin other than levonorgestrel or norethindrone, you’ll need a non-hormonal backup like condoms while you’re taking it and for 28 days after your last dose.

You don’t need to know which progestin is in yours (honestly, almost nobody does). Just bring me the exact brand name and I’ll check for you.

It’s completely optional

Saying no to JOURNAVX doesn’t change your care at all. Here’s what else you can do:

  • Topical numbing and cooling. You get these for every spicy treatment anyway.
  • Over-the-counter pain relief. Ibuprofen or acetaminophen works well for a lot of people and costs very little.
  • Nothing extra. Plenty of my patients do great with numbing alone, and some of them are tougher than I am.

Cost is a real factor too. JOURNAVX is a brand-name prescription with no generic, and insurance probably won’t cover it for this. Prices vary from pharmacy to pharmacy, so it’s worth calling around. If it doesn’t feel worth the money to you, just say so. I will never push you to pay for something you’re unsure about.

Bottom line

JOURNAVX is a genuinely new, non-opioid option that can make our spiciest treatments more comfortable for the right person. It won’t work miracles and it isn’t right for everyone. Whether you use it is always your call.

Curious whether it makes sense for your next treatment? Ask me at your consult, or text us at (805) 973-0793.


This post is for education and doesn’t replace a conversation with your provider. JOURNAVX® is a registered trademark of Vertex Pharmaceuticals Incorporated. Flora Aesthetics & Wellness is not affiliated with or endorsed by Vertex.

Sources

  • JOURNAVX Prescribing Information (Vertex, rev. July 2026)
  • FDA supplemental approval letter adding postoperative pain, January 23, 2026
  • FDA Drug Trials Snapshot: JOURNAVX
  • Vertex: Phase 4 data in aesthetic and reconstructive procedures, March 5, 2026
  • Managed Healthcare Executive: Phase 4 plastic surgery results, March 6, 2026

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

We use cookies to understand how our site is used and to improve our ads. You can decline at any time. Privacy Policy